DE3275997D1 - New cephem compounds, processes for their preparation and pharmaceutical antibacterial composition containing them - Google Patents

New cephem compounds, processes for their preparation and pharmaceutical antibacterial composition containing them

Info

Publication number
DE3275997D1
DE3275997D1 DE8282108384T DE3275997T DE3275997D1 DE 3275997 D1 DE3275997 D1 DE 3275997D1 DE 8282108384 T DE8282108384 T DE 8282108384T DE 3275997 T DE3275997 T DE 3275997T DE 3275997 D1 DE3275997 D1 DE 3275997D1
Authority
DE
Germany
Prior art keywords
processes
preparation
composition containing
antibacterial composition
cephem compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8282108384T
Other languages
English (en)
Inventor
Tsutomu Teraji
Kazuo Sakane
Jiro Goto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE3275997D1 publication Critical patent/DE3275997D1/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE8282108384T 1981-09-14 1982-09-11 New cephem compounds, processes for their preparation and pharmaceutical antibacterial composition containing them Expired DE3275997D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8127664 1981-09-14

Publications (1)

Publication Number Publication Date
DE3275997D1 true DE3275997D1 (en) 1987-05-14

Family

ID=10524486

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8282108384T Expired DE3275997D1 (en) 1981-09-14 1982-09-11 New cephem compounds, processes for their preparation and pharmaceutical antibacterial composition containing them

Country Status (4)

Country Link
US (1) US4550102A (de)
EP (1) EP0074645B1 (de)
JP (1) JPS5859991A (de)
DE (1) DE3275997D1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3207840A1 (de) * 1982-03-04 1983-09-15 Hoechst Ag, 6230 Frankfurt "cephalosporinderivate und verfahren zu ihrer herstellung"
US4690921A (en) * 1983-10-11 1987-09-01 Yamanouchi Pharmaceutical Co., Ltd. Cephalosporin compounds and salts thereof
DE3404906A1 (de) * 1984-02-11 1985-08-14 Bayer Ag, 5090 Leverkusen 1-oxadethiacephalosporinderivate sowie verfahren zu ihrer herstellung
DE3419014A1 (de) * 1984-05-22 1985-11-28 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von 7-amino-3-(3-formamidopyridinium)methyl-3-cephem-4-carboxylat und verwendung zur synthese von ss-lactamantibiotika
JPS6122089A (ja) * 1984-07-06 1986-01-30 Fujisawa Pharmaceut Co Ltd セフエム化合物
DK500285A (da) * 1984-11-02 1986-05-03 Glaxo Group Ltd Cephalosporinantibiotika
EP0554004A3 (en) * 1992-01-27 1993-11-24 Katayama Seisakusho Cephem compounds and antibacterial agents
US5929086A (en) 1996-05-10 1999-07-27 Pharmacia & Upjohn Company Topical administration of antimicrobial agents for the treatment of systemic bacterial diseases
TWI335332B (en) * 2001-10-12 2011-01-01 Theravance Inc Cross-linked vancomycin-cephalosporin antibiotics
TW200305422A (en) * 2002-03-18 2003-11-01 Shionogi & Co Broad spectrum cefem compounds
ES2335013T3 (es) * 2003-05-23 2010-03-18 Theravance, Inc. Antibioticos de glucopeptido-cefalosporina reticulados.
WO2013036783A2 (en) 2011-09-09 2013-03-14 Cubist Pharmaceuticals, Inc. Methods for treating intrapulmonary infections
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
MX2020004205A (es) 2013-03-15 2021-11-16 Merck Sharp & Dohme Llc Composiciones antibioticas de ceftolozano.
US20140274991A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane pharmaceutical compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
EP3043797B1 (de) 2013-09-09 2020-04-08 Merck Sharp & Dohme Corp. Behandlung von infektionen mit ceftolozan/tazobactam bei personen mit beeinträchtigter nierenfunktion
US20150094293A1 (en) 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5442998B2 (de) * 1971-10-22 1979-12-17
DE2760484C2 (de) * 1976-04-14 1992-12-03 Takeda Chemical Industries, Ltd., Osaka, Jp
DE2714880A1 (de) * 1977-04-02 1978-10-26 Hoechst Ag Cephemderivate und verfahren zu ihrer herstellung
AR229883A1 (es) * 1978-05-26 1983-12-30 Glaxo Group Ltd Procedimiento para la preparacion de antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)-acetamido)-3-(1-piridinometil)-cef-3-em-4-carboxilato
US4237128A (en) * 1979-04-12 1980-12-02 E. R. Squibb & Sons, Inc. 7-[2-(2-Amino-4-thiazolyl)-2-[(1-carboxy-1,1-dialkyl)alkoxyimino]acetamido]cephem sulfoxides
JPS5612397A (en) * 1979-05-25 1981-02-06 Glaxo Group Ltd Intermediate for manufacture of cephalosporin antibiotic
DE3006888A1 (de) * 1980-02-23 1981-09-10 Hoechst Ag, 6000 Frankfurt Cephalosporinderivate und verfahren zu ihrer herstellung
GR75644B (de) * 1980-06-18 1984-08-02 Fujisawa Pharmaceutical Co
EP0156118A1 (de) * 1980-08-29 1985-10-02 Fujisawa Pharmaceutical Co., Ltd. Ausgangsverbindungen für die Herstellung von Cephalosporinderivaten und Verfahren zu deren Herstellung
DE3118732A1 (de) * 1981-05-12 1982-12-02 Hoechst Ag, 6000 Frankfurt Cephalosporinderivate und verfahren zu ihrer herstellung
US4394503A (en) * 1981-12-07 1983-07-19 Bristol-Myers Company Cephalosporin derivatives

Also Published As

Publication number Publication date
EP0074645A2 (de) 1983-03-23
US4550102A (en) 1985-10-29
EP0074645B1 (de) 1987-04-08
EP0074645A3 (en) 1984-06-13
JPS5859991A (ja) 1983-04-09
JPH0354111B2 (de) 1991-08-19

Similar Documents

Publication Publication Date Title
DE3279470D1 (en) New cephem compounds, processes for their preparation, pharmaceutical compositions containing them and their starting compounds
DE3263633D1 (en) Imidazodiazepines, process for their preparation and pharmaceutical compositions containing them
DE2967410D1 (en) Cephem and cepham compounds, processes for their preparation, pharmaceutical compositions containing them
IL67206A0 (en) Bicyclic compounds,their preparation and pharmaceutical compositions containing them
DE2966913D1 (en) Cephem compounds, processes for their preparation and pharmaceutical compositions containing them
DE2966293D1 (en) Cephem compounds, processes for their preparation and pharmaceutical compositions containing them
ZA816080B (en) 7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-naphthyridine-3-carboxylic acids,processes for their preparation and antibacterial agents containing these compounds
DE3275997D1 (en) New cephem compounds, processes for their preparation and pharmaceutical antibacterial composition containing them
EP0133678A3 (en) New cephem compounds, processes for preparation thereof and pharmaceutical compositions containing them
IL64847A0 (en) Hexapyranose compounds,their manufacture and pharmaceutical compositions containing them
IL83760A0 (en) Cephem compounds,processes for the preparation thereof and pharmaceutical compositions containing the same
DE3279649D1 (en) New cephem compounds, processes for their preparation, pharmaceutical compositions containing them and intermediate products for their preparation
IL80669A0 (en) Cephem compounds,processes for the preparation thereof and pharmaceutical compositions containing the same
DE3380627D1 (en) Cephem compounds, process and intermediates for their preparation and pharmaceutical compositions containing them
DE3069560D1 (en) Cephem compounds, processes for their preparation and pharmaceutical compositions containing them
DE3176154D1 (en) Cephem compounds, processes for their preparation, pharmaceutical compositions containing them and their starting compounds
DE3069364D1 (en) Cephem compounds, processes for their preparation and pharmaceutical compositions containing them
DE2966187D1 (en) Beta-lactam antibacterial compounds, their preparation and pharmaceutical compositions containing them
DE3162109D1 (en) Cephalosporin sulfoxides, process for their preparation and pharmaceutical compositions containing them
DE3273781D1 (en) Novel thiazole compounds, process for their preparation, and medicinal composition containing same
JPS57158790A (en) Antibacterial compound, manufacture and medicinal composition containing same
IL65368A0 (en) Mercapto acyl-carnitines,process for their preparation and pharmaceutical compositions containing same
DE3174719D1 (en) New cephem compounds, processes for preparation thereof and pharmaceutical composition comprising the same
DE3070258D1 (en) Cephem compounds, processes for their preparation and pharmaceutical compositions containing them
DE3372968D1 (en) Heterocyclyl-thio compounds, process for their preparation, pharmaceutical compositions containing them and their use

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee